PPPDE2, a member of the protein phosphatase family, serves a crucial role in cellular processes through its enzymatic activity in dephosphorylation. This protein is implicated in various signaling pathways, contributing to the regulation of cellular growth, differentiation, and apoptosis. The function of PPPDE2 encompasses the selective removal of phosphate groups from serine and threonine residues on target proteins, a critical post-translational modification that alters the activity, stability, and localization of these proteins. By modulating the phosphorylation status of key signaling molecules, PPPDE2 influences cellular responses to external stimuli, maintaining cellular homeostasis and regulating cell cycle progression. Its activity is finely tuned within the cell, with implications for the control of numerous biological functions and the maintenance of physiological balance.
The inhibition of PPPDE2 involves the disruption of its phosphatase activity, leading to altered phosphorylation patterns of its substrates and consequent perturbations in signaling pathways. Inhibitors of PPPDE2 act by binding to the active site or allosteric sites, preventing substrate access or altering the enzyme's conformation to reduce its catalytic efficiency. This inhibition can lead to the accumulation of phosphorylated substrates, impacting various cellular processes by either prolonging or diminishing the signaling events they mediate. The specific mechanisms of inhibition are diverse, encompassing competitive, non-competitive, and uncompetitive modalities, each affecting the enzyme's function in distinct manners. By targeting PPPDE2, inhibitors can effectively modulate the dynamic phosphorylation networks within the cell, offering insights into the enzyme's role in cellular physiology and the potential consequences of its dysregulation. Understanding the intricate mechanisms of PPPDE2 inhibition provides a foundation for elucidating the complex regulatory networks that govern cellular behavior and the potential implications of perturbations in these systems.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that could increase the levels of ubiquitinated proteins, potentially affecting the substrate availability for PPPDE2. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Another proteasome inhibitor that works similarly to MG132, increasing ubiquitinated proteins that could be substrates for PPPDE2. | ||||||
1,10-Phenanthroline | 66-71-7 | sc-255888 sc-255888A | 2.5 g 5 g | $23.00 $32.00 | ||
Metalloprotease inhibitor that could chelate metal ions necessary for PPPDE2's catalytic activity if it is a metalloprotease. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor that may alter signaling pathways, which could indirectly affect PPPDE2's role if it is involved in these pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that could modify signaling pathways and possibly influence PPPDE2's function or substrate specificity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that could change cellular responses and indirectly influence PPPDE2 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK signaling which might modulate stress or apoptosis pathways, potentially affecting PPPDE2. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that could indirectly affect PPPDE2 by altering its role within the PI3K/Akt pathway. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
A pan-caspase inhibitor that could influence apoptotic pathways and potentially affect PPPDE2 if it regulates caspase activity. | ||||||